Cryogenic spray, cutaneous
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
19-07-2021
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Emergo Asia Pacific Pty Ltd T/a Emergo Australia
Class:
Class IIa
Manufactured by:
CryoConcepts LP 1100 Conroy Place, Easton, PA, 18040 United States Of America
Therapeutic area:
44724 - Cryogenic spray, cutaneous
Therapeutic indications:
This multi-use disposable device is intended for the surgical destruction of target tissue by applying cryogenic gases at extreme low temperature. This list below shows examples of the types of lesions that can be treated. ? Genital Lesions ? Seborrheic Keratosis ? Verruca Plantaris ? Verruca Plana ? Lentigo ? Molluscum Contagiosum ? Skin Tags ? Verruca Vulgaris ? Actinic Keratosis
Authorization status:
A
Authorization date:
2021-06-03
